Search research articles
Contact Us
Filters
Showing results (11-20 of 144) with videos related to
Page
of 15
Sort By:
Journal of the Advanced Practitioner in Oncology
|
February 18, 2021
Precision Oncology Comes of Age: Tumor-Agnostic Approaches
Colleen Lewis, R Donald Harvey
Cancer
|
August 16, 2016
Precision, accuracy, and resolution-Dose selection of oral anticancer agents
Tyler J Beardslee, R Donald Harvey
Clinical Pharmacology and Therapeutics
|
July 3, 2014
Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents
R Donald Harvey, E T Morgan
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 1, 2021
Tyrosine Kinase Inhibitors, Antibody-Drug Conjugates, and Proteolysis-Targeting Chimeras: The Pharmacology of Cutting-Edge Lung Cancer Therapies
Jennifer W Carlisle, R Donald Harvey
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 2, 2010
Histological and genetic markers for non-small-cell lung cancer: customizing treatment based on individual tumor biology
Val R Adams, R Donald Harvey
Journal of the Advanced Practitioner in Oncology
|
November 21, 2017
Navigating the Landscape of Molecular Testing and Targeted Treatment of Non-Small Cell Lung Cancer
Sukhmani K Padda, R Donald Harvey
JAMA Oncology
|
October 18, 2019
A Cost-Focused Alternative Cancer Medication Dispensing Strategy-"Pack Splitting"
R Donald Harvey, Mark J Ratain
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 25, 2010
Iron overload in myelodysplastic syndromes. Introduction
R Donald Harvey, Christopher A Fausel
Oral Oncology
|
September 17, 2014
Pre-medications for cetuximab induced infusion reactions - commentary
Trevor McKibbin, R Donald Harvey, Nabil F Saba
Expert Review of Anticancer Therapy
|
June 11, 2021
Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity
Michelle Shayne, R Donald Harvey, Gary H Lyman
Page
of 15
Search research articles
Search
Showing results (11-20 of 144) with videos related to
Sort By:
Page
of 15
Journal of the Advanced Practitioner in Oncology
|
February 18, 2021
Precision Oncology Comes of Age: Tumor-Agnostic Approaches
Colleen Lewis, R Donald Harvey
Cancer
|
August 16, 2016
Precision, accuracy, and resolution-Dose selection of oral anticancer agents
Tyler J Beardslee, R Donald Harvey
Clinical Pharmacology and Therapeutics
|
July 3, 2014
Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents
R Donald Harvey, E T Morgan
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 1, 2021
Tyrosine Kinase Inhibitors, Antibody-Drug Conjugates, and Proteolysis-Targeting Chimeras: The Pharmacology of Cutting-Edge Lung Cancer Therapies
Jennifer W Carlisle, R Donald Harvey
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 2, 2010
Histological and genetic markers for non-small-cell lung cancer: customizing treatment based on individual tumor biology
Val R Adams, R Donald Harvey
Journal of the Advanced Practitioner in Oncology
|
November 21, 2017
Navigating the Landscape of Molecular Testing and Targeted Treatment of Non-Small Cell Lung Cancer
Sukhmani K Padda, R Donald Harvey
JAMA Oncology
|
October 18, 2019
A Cost-Focused Alternative Cancer Medication Dispensing Strategy-"Pack Splitting"
R Donald Harvey, Mark J Ratain
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 25, 2010
Iron overload in myelodysplastic syndromes. Introduction
R Donald Harvey, Christopher A Fausel
Oral Oncology
|
September 17, 2014
Pre-medications for cetuximab induced infusion reactions - commentary
Trevor McKibbin, R Donald Harvey, Nabil F Saba
Expert Review of Anticancer Therapy
|
June 11, 2021
Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity
Michelle Shayne, R Donald Harvey, Gary H Lyman
Page
of 15